Saturday, July 19, 2025 | 11:57 AM ISTहिंदी में पढें
Glenmark Pharmaceuticals Ltd
Intimation Under Regulation 30 (5) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015
04:21 PM, 1st Jul 2025
Pursuant to Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 details of Key Managerial Personnel of the Company who are severally authorised for determining materiality of an event or information and for the purpose of making disclosures to stock exchanges is attached.
